Evidence map›Paper›PMID 26610681›Full record

ReviewDer Radiologe2015

[Combined PET-MRI of the abdomen].

Tibor Vag, M Eiber, M Schwaiger

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Radiologe, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tibor VagKlinik für Nuklearmedizin, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland. tibor.vag@tum.de.
M EiberKlinik für Nuklearmedizin, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland.
M SchwaigerKlinik für Nuklearmedizin, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first fully integrated combined positron emission tomography-magnetic resonance imaging (PET-MRI) scanners have been clinically available since 2010. Large prospective studies regarding indications and diagnostic accuracy of this new modality are not yet available; however, preliminary studies have shown a higher diagnostic accuracy and confidence compared to PET-computed tomography (PET-CT) in regions where MRI is known to be superior to CT, such as the liver. The benefit of MRI in accurate lesion characterization and the additional value of diffusion-weighted imaging (DWI) as a complementary functional modality by means of the apparent diffusion coefficient (ADC) is apparent in entities with low tracer uptake (e.g. due to small size) and a decreased or absent accumulation pattern on PET.

Indexed as

AbdomenHumansImage EnhancementMagnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyReproducibility of ResultsSensitivity and SpecificityAbdomenColorectal cancerLiver metastasesNeuroendocrine tumorsPositron emission tomography-computed tomography

Identifiers

PMID26610681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.